Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.46
-0.01 (-0.06%)
At close: May 14, 2026, 4:00 PM EDT
16.46
0.00 (0.00%)
After-hours: May 14, 2026, 4:10 PM EDT
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 4 analysts that cover Select Medical Holdings stock have a consensus rating of "Hold" and an average price target of $15.5, which forecasts a -5.83% decrease in the stock price over the next year. The lowest target is $14 and the highest is $16.5.
Price Target: $15.5 (-5.83%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Select Medical Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy → Hold Downgrades $17 → $17 | Buy → Hold | Downgrades | $17 → $17 | +0.24% | May 13, 2026 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 4, 2026 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $19 → $17 | Buy → Hold | Downgrades | $19 → $17 | +0.24% | Mar 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +15.43% | Feb 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +21.51% | Oct 8, 2025 |
Financial Forecast
Revenue This Year
5.75B
from 5.45B
Increased by 5.43%
Revenue Next Year
6.03B
from 5.75B
Increased by 4.80%
EPS This Year
1.28
from 1.16
Increased by 10.05%
EPS Next Year
1.42
from 1.28
Increased by 10.92%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.0B | 6.3B | |
| Avg | 5.7B | 6.0B | |
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.1% | 10.0% | |
| Avg | 5.4% | 4.8% | |
| Low | 1.7% | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.46 | 1.58 | |
| Avg | 1.28 | 1.42 | |
| Low | 1.17 | 1.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.3% | 22.9% | |
| Avg | 10.0% | 10.9% | |
| Low | 0.1% | 2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.